TRPV1 and osteoarthritis: The peripherally restricted TRPV1 antagonist, A-425619, has been previously shown to reverse thermal and mechanical hypersensitivity in rat CFA models and also restore weight bearing ability in rat osteoarthritis models (Honore et al., 2005).